JP Morgan Chase
TMCI icon

JP Morgan Chase’s Treace Medical Concepts TMCI Stock Holding History

JP Morgan Chase’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.7K Sell
9,305
-13,142
-59% -$36.1K ﹤0.01% 6512
2026
Q1 		$26.9K Sell
22,447
-41,069
-65% -$81.9K ﹤0.01% 6442
2025
Q4 		$156K Sell
63,516
-1,550,016
-96% -$6.73M ﹤0.01% 5653
2025
Q3 		$10.8M Sell
1,613,532
-163,680
-9% -$1.07M ﹤0.01% 2641
2025
Q2 		$10.5M Sell
1,777,212
-71,785
-4% -$468K ﹤0.01% 2518
2025
Q1 		$15.5M Sell
1,848,997
-128,222
-6% -$1.15M ﹤0.01% 2139
2024
Q4 		$14.7M Buy
1,977,219
+714,984
+57% +$4.78M ﹤0.01% 2329
2024
Q3 		$7.32M Buy
1,262,235
+861,689
+215% +$5.53M ﹤0.01% 2898
2024
Q2 		$2.66M Buy
400,546
+22,674
+6% +$183K ﹤0.01% 3538
2024
Q1 		$4.93M Buy
377,872
+1,219
+0.3% +$16.3K ﹤0.01% 3119
2023
Q4 		$4.8M Buy
376,653
+28,085
+8% +$284K ﹤0.01% 3129
2023
Q3 		$4.57M Sell
348,568
-30,545
-8% -$559K ﹤0.01% 2908
2023
Q2 		$9.7M Buy
379,113
+97,910
+35% +$2.53M ﹤0.01% 2311
2023
Q1 		$7.08M Buy
281,203
+47,284
+20% +$1.11M ﹤0.01% 2558
2022
Q4 		$5.38M Buy
233,919
+4,578
+2% +$105K ﹤0.01% 2760
2022
Q3 		$5.06M Buy
229,341
+3,491
+2% +$67.5K ﹤0.01% 2727
2022
Q2 		$3.24M Sell
225,850
-9,323
-4% -$157K ﹤0.01% 3154
2022
Q1 		$4.45M Sell
235,173
-28,334
-11% -$551K ﹤0.01% 3102
2021
Q4 		$4.91M Buy
263,507
+176,598
+203% +$3.64M ﹤0.01% 3080
2021
Q3 		$2.34M Sell
86,909
-18,905
-18% -$520K ﹤0.01% 3666
2021
Q2 		$3.31M Buy
+105,814
New +$3.37M ﹤0.01% 3392

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

JP Morgan Chase's TMCI Position: Q2 2026 in Review

JP Morgan Chase reduced its Treace Medical Concepts (TMCI) stake by 59% in Q2 2026, selling an estimated $36.1K and leaving 9,305 shares worth $39.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6512.

JP Morgan Chase first reported a position in TMCI in Q2 2021 and has held it in 21 quarters since. The position peaked at $15.5M in Q1 2025. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • JP Morgan Chase held 9,305 shares of Treace Medical Concepts worth $39.7K as of Q2 2026.
  • JP Morgan Chase sold 13,142 Treace Medical Concepts shares in Q2 2026, an estimated $36.1K.
  • Treace Medical Concepts made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6512 holding.
  • JP Morgan Chase first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 21 quarters since.
  • JP Morgan Chase's Treace Medical Concepts position peaked at $15.5M in Q1 2025.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.